What the Latest Public Data Shows About Liver King Steroids
The Liver King, whose real name is Brian Johnson, has publicly promoted a raw-meat-heavy ancestral diet and a supplement line. Public records and media reports have linked his brand to anabolic steroids and related compounds, though his company has not publicly disclosed a full list of ingredients or dosages. The U.S. Food and Drug Administration has issued warnings about unapproved steroid products sold online, noting that many such products contain undeclared active pharmaceutical ingredients. According to the FDA's website, products marketed as "natural" or "herbal" can still contain synthetic steroids that pose serious health risks. Johnson's company markets its supplements as part of a lifestyle brand, but independent lab analyses have frequently found undisclosed anabolic agents in similar products sold through direct-to-consumer channels. The FDA maintains a searchable database of warning letters and product seizures, which can be used to trace enforcement actions related to unapproved steroid sales.
Anabolic steroids are synthetic variations of testosterone, and they are classified as controlled substances in the United States. The Drug Enforcement Administration lists several anabolic steroids as Schedule III controlled substances, meaning they have a recognized medical use but also a high potential for abuse. Public health data from the Centers for Disease Control and Prevention shows that steroid misuse can lead to liver damage, cardiovascular disease, hormonal imbalances, and psychiatric effects. The FDA has approved a limited number of anabolic steroids for specific medical conditions, such as delayed puberty and muscle wasting from HIV/AIDS. Any steroid product sold for bodybuilding or performance enhancement without a valid prescription is considered unapproved and illegal. The FDA's Office of Criminal Investigations works with other agencies to track the supply chain of such products, including those marketed through social media influencers and high-profile brand ambassadors.
Regulatory Actions and Enforcement Trends
The FDA regularly issues warning letters to companies selling products that contain undisclosed anabolic steroids. In recent enforcement actions, the agency has targeted online retailers and supplement brands that use terms like "prohormone" or "natural steroid" to market products with actual steroid content. The Federal Trade Commission has also pursued cases against companies making false claims about the safety and efficacy of muscle-building supplements. According to the FTC's official site, deceptive health claims are a top priority for enforcement, especially when products pose serious physical risks. The FDA's Bad Ad Program tracks adverse event reports tied to supplements, and some of these reports involve liver injury and cardiovascular events linked to undisclosed steroids. Companies that market such products can face seizure orders, injunctions, and criminal prosecution if they violate the Federal Food, Drug, and Cosmetic Act.
Publicly traded companies in the supplement industry are subject to SEC disclosure rules, and any material legal or regulatory action must be reported to investors. The SEC's EDGAR database allows users to search for filings that mention FDA warning letters, product recalls, or litigation related to supplement safety. In recent years, several supplement companies have disclosed regulatory scrutiny in their 10-K and 10-Q filings, noting potential financial impacts from enforcement actions. The FDA's Dietary Supplement Office works with the FTC to coordinate enforcement, and both agencies publish joint guidance on labeling and marketing claims. For consumers, the FDA's website provides a searchable index of tainted products, which includes supplements that tested positive for hidden steroids. These public records are a key source of data for tracking the prevalence of undisclosed anabolic agents in the supplement market.
Health Risks, Public Perception, and Industry Impact
Medical literature consistently identifies liver toxicity as a major risk of anabolic steroid use, particularly with oral 17-alpha-alkylated steroids. The World Health Organization's Global Surveillance System for Substandard and Falsified Medical Products tracks reports of adulterated health products, including those containing undeclared steroids. Public health agencies in the European Union and the United States have issued alerts about dietary supplements that caused acute liver injury. The American Association for the Study of Liver Diseases has published case reports linking